Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
This update summary includes a preview of the changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The full Update will be available as a PDF on our website(external link). The changes will be published in the online HML around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
18 January 2023 - preview of changes for February 2023
Pharmaceutical |
Change |
---|---|
Abacavir sulphate with lamivudine (Kivexa) tab 600 mg with lamivudine 300 mg |
price increase |
Adalimumab (Amgevita) inj 20 mg per 0.4 ml prefilled syringe and inj 40 mg per 0.8 ml prefilled pen and syringe |
amended restriction criteria |
Adrenaline inj 0.15 mg per 0.3 ml auto-injector (Epipen Jr) and inj 0.3 mg per 0.3 ml auto-injector (Epipen) |
New listing
|
Adrenaline (DBL Adrenaline) inj 1 in 1,000, 1 ml ampoule |
price increase |
Amoxicillin (Alphamox) cap 250 mg and 500 mg |
price increase |
Bisoprolol fumarate (Bisoprolol Viatris) tab 2.5 mg, 5 mg and 10 mg |
New listing
|
Cabergoline (Dostinex) tab 0.5 mg, 2 and 8 tab pack |
price increase |
Calcium folinate (DBL Leucovorin Calcium) tab 15 mg |
price increase |
Ceftaroline fosamil (Zinforo) inj 600 mg vial |
price increase |
Cetomacrogol with glycerol (Evara) crm 90% with glycerol 10%, 500 ml |
price decrease and addition of PSS |
Cetomacrogol with glycerol (Evara) crm 90% with glycerol 10%, 1,000 ml |
price increase and addition of PSS |
Clindamycin (Dalacin C) cap 150 mg |
price increase |
Cytarabine (Pfizer) inj 20 mg per ml, 5 ml vial and inj 100 mg per ml, 20 ml vial |
price increase |
Dacarbazine (DBL Dacarbazine) inj 200 mg vial |
price increase |
Dantrolene cap 25 mg (Dantrium) and inj 20 mg vial (Dantrium IV) |
price increase |
Daunorubicin (Pfizer) inj 2 mg per ml, 10 ml |
price increase |
Diazepam (Hospira) inj 5 mg per ml, |
price increase |
Dinoprostone (Prostin E2) vaginal gel |
price increase |
Dosulepin [dothiepin] hydrochloride (Dosulepin Viatris) cap 25 mg |
new listing (p’code 2636441) |
Efavirenz with emtricitabine and tenofovir disoproxil (Viatris) tab 600 mg with emtricitabine 200 mg and tenofovir disoproxil 245 mg (300 mg as a maleate) |
new listing (p’code 2644967) |
Emtricitabine with tenofovir disoproxil (Tenofovir Disoproxil Emtricitabine Viatris) tab 200 mg with tenofovir disoproxil 245 mg (300 mg as a maleate) |
new listing (p’code 2638088) |
Enteral feed 1kcal/ml (Fresubin Original) liquid 3.8 g protein, 13.8 g carbohydrate and 3.4 g fat per 100 ml, bag, 1,000 ml |
new listing (p’code 2651734) |
Enteral feed 1.5kcal/ml (Fresubin HP Energy) liquid 7.5 g protein, 17 g carbohydrate and 5.8 g fat per 100 ml, bag, 1,000 ml |
new listing (p’code 2651718) |
Enteral feed 2 kcal/ml (Fresubin 2kcal HP) liquid 10 g protein, 17.5 g carbohydrate and 10 g fat per 100 ml, bag, 500 ml |
new listing (p’code 2651696) |
Enteral feed with fibre 1kcal/ml (Fresubin Original Fibre) liquid 3.8 g protein, 13.0 g carbohydrate, 3.4 g fat and 1.5 g fibre per 100 ml, bag, 1,000 ml |
new listing (p’code 2651726) |
Enteral feed with fibre 1.5kcal/ml (Fresubin HP Energy Fibre) liquid 7.5 g protein, 16.2 g carbohydrate, 5.8 g fat and 1.5 g fibre per 100 ml, bag, 1,000 ml |
new listing (p’code 2651742) |
Eptifibatide (Eptifibatide Viatris) inj 2 mg per ml, 10 ml vial and inj 750 mcg per ml, 100 ml vial |
New listing
|
Ethinyloestradiol with norethisterone (Brevinor 1/28) tab 35 mcg with norethisterone 1 mg and 7 inert tab |
price increase |
Fluconazole oral liquid 50 mg per 5 ml, 35 ml (Diflucan) and inj 2 mg per ml, 50 ml and 100 ml vial (Fluconazole-Baxter) |
price increase |
Fluticasone (Flixotide Accuhaler) powder for inhalation, 50 mcg, 100 mcg and 250 mcg per dose, 60 dose |
price decrease |
Gentamicin sulphate (Pfizer) inj 40 mg per ml, 2 ml ampoule |
price increase |
Heparin sodium (Heparin Sodium Panpharma) inj 5,000 iu per ml, 5 ml vial |
new listing and addition of PSS (p’code 2651815) |
Heparin sodium (Pfizer) inj 5,000 iu per ml, 5 ml vial |
to be delisted 1 July 2023 |
Heparin sodium (Pfizer) inj 1,000 iu per ml, 5 ml ampoule |
price increase |
High protein enteral feed 1.2 kcal/ml (Fresubin Intensive) liquid 10 g protein, 12.9 g carbohydrate and 3.2 g fat and 0.64 g fibre per 100 ml, bag, 500 ml |
new listing (p’code 2651750) |
Infliximab (Remicade) inj 100 mg |
price decrease, amended HSS and restriction criteria |
Lamivudine (Lamivudine Viatris) tab 150 mg |
new listing (p’code 2638045) |
Lidocaine [lignocaine] hydrochloride (Lidocaine-Baxter) inj 1%, 20 ml vial, inj 2%, 5 ml ampoule and inj 2%, 20 ml vial |
price increase |
Medroxyprogesterone acetate (Depo-Provera) inj 150 mg per ml, 1 ml syringe |
price increase |
Minoxidil (Loniten) tab 10 mg |
price increase |
Misoprostol (Cytotec) tab 200 mcg |
price increase |
Nicotine (Habitrol (Mint)) gum 2 mg, 204 pack |
new listing (p’code 2640562) |
Nicotine (Habitrol) patch 7 mg, 14 mg and 21 mg per 24 hours and lozenge 1 mg and 2 mg |
price increase |
Paediatric enteral feed 1 kcal/ml (Frebini Original) liquid 2.5 g protein, 12.5 g carbohydrate and 4.4 g fat per 100 ml, 500 ml |
new listing (p’code 2651777) |
Paediatric Paediatric enteral feed 1.5 kcal/ml (Frebini Energy) liquid 3.8 g protein, 18.7 g carbohydrate and 6.7 g fat per 100 ml, 500 ml |
new listing (p’code 2651793) |
Paediatric enteral feed with fibre 1kcal/ml (Frebini Original Fibre) liquid 2.5 g protein, 12.1 g carbohydrate, 4.5 g fat and 0.8 g fibre per 100 ml, 500 ml |
new listing (p’code 2651785) |
Paediatric enteral feed with fibre 1.5kcal/ml (Frebini Energy Fibre) liquid 3.8 g protein, 18.1 g carbohydrate, 6.7 g fat and 1.1 g fibre per 100 ml, 500 ml |
new listing (p’code 2651807) |
Pamidronate disodium (Pamisol) inj 3 mg, 6 mg and 9 mg per ml, 10 ml vial |
price increase |
Pantoprazole (Panzop Relief) tab EC 20 mg and 40 mg |
New pack size listing
100 tab pack to be delisted 1 July 2023 |
Peptide-based enteral feed 1kcal/ml (Survimed OPD) liquid 4.5 g protein, 14.3 g carbohydrate and 2.8 g fat per 100 ml, bag, 500 ml |
new listing (p’code 2651769) |
Phenylephrine hydrochloride (Neosynephrine HCL) inj 10 mg per ml, 1 ml ampoule |
price increase |
Promethazine hydrochloride (Hospira) inj 25 mg per ml, 2 ml ampoule |
price increase |
Rifabutin (Mycobutin) cap 150 mg |
price increase |
Sulfasalazine tab 500 mg (Salazopyrin) and tab EC 500 mg (Salazopyrin EN) |
price increase |
Solifenacin succinate (Solifenacin Viatris) tab 5 mg and 10 mg |
New listing
|
Teriparatide (Forteo) inj 250 mcg per ml, 2.4 ml cartridge |
new Pharmacode listing (p’code 2650908) |
Ustekinumab (Stelara) inj 130 mg vial and inj 90 mg per ml, 1 ml prefilled syringe |
New listing
|
Vedolizumab (Entyvio) inj 300 mg vial |
new listing (p’code 2649144) |